235 related articles for article (PubMed ID: 8690416)
1. Regulation of the last two enzymatic reactions in cholesterol biosynthesis in rats: effects of BM 15.766, cholesterol, cholic acid, lovastatin, and their combinations.
Honda A; Shefer S; Salen G; Xu G; Batta AK; Tint GS; Honda M; Chen TC; Holick MF
Hepatology; 1996 Aug; 24(2):435-9. PubMed ID: 8690416
[TBL] [Abstract][Full Text] [Related]
2. Regulation of early cholesterol biosynthesis in rat liver: effects of sterols, bile acids, lovastatin, and BM 15.766 on 3-hydroxy-3-methylglutaryl coenzyme A synthase and acetoacetyl coenzyme A thiolase activities.
Honda A; Salen G; Nguyen LB; Xu G; Tint GS; Batta AK; Shefer S
Hepatology; 1998 Jan; 27(1):154-9. PubMed ID: 9425931
[TBL] [Abstract][Full Text] [Related]
3. Treatment of the cholesterol biosynthetic defect in Smith-Lemli-Opitz syndrome reproduced in rats by BM 15.766.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Salen L; Tint GS
Gastroenterology; 1995 Oct; 109(4):1301-7. PubMed ID: 7557099
[TBL] [Abstract][Full Text] [Related]
4. Abnormal cholesterol biosynthesis in the Smith-Lemli-Opitz syndrome.
Salen G; Tint GS; Xu G; Batta AK; Irons M; Elias ER
Ital J Gastroenterol; 1995 Dec; 27(9):506-8. PubMed ID: 8919321
[TBL] [Abstract][Full Text] [Related]
5. Blocking late cholesterol biosynthesis inhibits the growth of transplanted Morris hepatomas (7288CTC) in rats.
Xu G; Salen G; Lea M; Tint GS; Nguyen LB; Batta AK; Chen TS; Shefer S
Hepatology; 1996 Aug; 24(2):440-5. PubMed ID: 8690417
[TBL] [Abstract][Full Text] [Related]
6. Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats.
Xu G; Salen G; Shefer S; Ness GC; Chen TS; Zhao Z; Tint GS
J Clin Invest; 1995 Jan; 95(1):76-81. PubMed ID: 7814648
[TBL] [Abstract][Full Text] [Related]
7. Effects of drugs affecting cholesterol biosynthesis pathway on BM 15.766-induced 7-dehydrocholesterol accumulation in rats. An animal model for testing compounds reducing cholesterol synthesis.
Pill J; Stegmeier K; Schmidt FH
Methods Find Exp Clin Pharmacol; 1990 Apr; 12(3):167-74. PubMed ID: 2352446
[TBL] [Abstract][Full Text] [Related]
8. Rapid identification of Smith-Lemli-Opitz syndrome homozygotes and heterozygotes (carriers) by measurement of deficient 7-dehydrocholesterol-delta 7-reductase activity in fibroblasts.
Shefer S; Salen G; Honda A; Batta A; Hauser S; Tint GS; Honda M; Chen T; Holick MF; Nguyen LB
Metabolism; 1997 Jul; 46(7):844-50. PubMed ID: 9225842
[TBL] [Abstract][Full Text] [Related]
9. RPR 107393, a potent squalene synthase inhibitor and orally effective cholesterol-lowering agent: comparison with inhibitors of HMG-CoA reductase.
Amin D; Rutledge RZ; Needle SN; Galczenski HF; Neuenschwander K; Scotese AC; Maguire MP; Bush RC; Hele DJ; Bilder GE; Perrone MH
J Pharmacol Exp Ther; 1997 May; 281(2):746-52. PubMed ID: 9152381
[TBL] [Abstract][Full Text] [Related]
10. Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes.
Shefer S; Salen G; Batta AK; Honda A; Tint GS; Irons M; Elias ER; Chen TC; Holick MF
J Clin Invest; 1995 Oct; 96(4):1779-85. PubMed ID: 7560069
[TBL] [Abstract][Full Text] [Related]
11. [Elevation of 7-dehydrocholesterol concentrations in serum and liver and pericentral peroxisome proliferation in hepatocytes of rats after inhibition of cholesterol biosynthesis by BM 15,766].
Weiss MC; Baumgart E; Fahimi HD; Pill H; Rebel W; Hartig F
Berl Munch Tierarztl Wochenschr; 1995 Feb; 108(2):66-9. PubMed ID: 7786281
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3,4-di(OH)-cinnamate synthetic derivative on plasma and hepatic cholesterol level and antioxidant enzyme activities in high cholesterol-fed rats.
Park EJ; Lee S; Jeong TS; Bok SH; Lee MK; Park YB; Choi MS
J Biochem Mol Toxicol; 2004; 18(5):279-87. PubMed ID: 15549704
[TBL] [Abstract][Full Text] [Related]
13. Regulation of hepatic lanosterol 14 alpha-demethylase gene expression by dietary cholesterol and cholesterol-lowering agents.
Ness GC; Gertz KR; Holland RC
Arch Biochem Biophys; 2001 Nov; 395(2):233-8. PubMed ID: 11697861
[TBL] [Abstract][Full Text] [Related]
14. 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors unmask cryptic regulatory mechanisms.
Lopez D; Chambers CM; Ness GC
Arch Biochem Biophys; 1997 Jul; 343(1):118-22. PubMed ID: 9210653
[TBL] [Abstract][Full Text] [Related]
15. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs.
Davis HR; Pula KK; Alton KB; Burrier RE; Watkins RW
Metabolism; 2001 Oct; 50(10):1234-41. PubMed ID: 11586500
[TBL] [Abstract][Full Text] [Related]
16. Abnormal cholesterol biosynthesis in sitosterolaemia and the Smith-Lemli-Opitz syndrome.
Salen G; Shefer S; Batta AK; Tint GS; Xu G; Honda A
J Inherit Metab Dis; 1996; 19(4):391-400. PubMed ID: 8884563
[TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase activity is inhibited by cholesterol and up-regulated by sitosterol in sitosterolemic fibroblasts.
Honda A; Salen G; Honda M; Batta AK; Tint GS; Xu G; Chen TS; Tanaka N; Shefer S
J Lab Clin Med; 2000 Feb; 135(2):174-9. PubMed ID: 10695663
[TBL] [Abstract][Full Text] [Related]
18. Reduction of BM 15.766-induced 7-dehydrocholesterol accumulation by bezafibrate and mevinolin in rats. A non-isotopic in vivo test system for compounds reducing cholesterol synthesis.
Pill J; Witte EC; Schmidt FH
Naunyn Schmiedebergs Arch Pharmacol; 1990 Jun; 341(6):552-6. PubMed ID: 2392158
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro.
Flint OP; Masters BA; Gregg RE; Durham SK
Toxicol Appl Pharmacol; 1997 Jul; 145(1):91-8. PubMed ID: 9221828
[TBL] [Abstract][Full Text] [Related]
20. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
Pappu AS; Bacon SP; Illingworth DR
J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
